Complete Blood Count For Paediatric

Disclaimer: This information is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider for any questions regarding your or your patient's medical condition. Clinical judgment is paramount in patient care decisions.

Overview

• Definition: The Complete Blood Count (CBC) is a routine blood test that provides quantitative and qualitative information about the cellular components of blood: red blood cells (RBCs), white blood cells (WBCs), and platelets. In paediatrics, the CBC is an invaluable tool for screening, diagnosing, and monitoring a wide range of hematologic and non-hematologic conditions. It typically includes RBC count, hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), WBC count with differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils), and platelet count.
• Epidemiology: While the CBC itself does not have an epidemiology, its use is widespread in paediatric practice. Common reasons for CBC testing in children include:
  • Anemia: Iron deficiency anemia is the most common nutritional deficiency globally, frequently affecting infants and young children. Anemia due to chronic disease or other causes is also prevalent.
  • Infections: Viral and bacterial infections are common in childhood, often causing changes in WBC count and differential.
  • Inflammation: Systemic inflammatory conditions can alter CBC parameters.
  • Bleeding/Bruising: Thrombocytopenia or platelet dysfunction is a common cause of easy bruising or bleeding in children.
  • Malignancy Screening: Persistent cytopenias or cytoses, especially with blasts, can indicate leukaemia or other hematologic malignancies, which are a significant concern in paediatrics.
  • Routine screening: Often performed during well-child visits or pre-operatively.
• Classification: The CBC measures three main cellular lines and their components:
  • Erythroid Series (Red Blood Cells):
    • RBC count, Hemoglobin (Hb), Hematocrit (Hct)
    • RBC indices: Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC), Red Cell Distribution Width (RDW)
    • Reticulocyte count (often ordered as an add-on)
  • Leukocyte Series (White Blood Cells):
    • Total WBC count
    • Differential count: Neutrophils (segmented and bands), Lymphocytes, Monocytes, Eosinophils, Basophils
  • Megakaryocyte Series (Platelets):
    • Platelet count
    • Mean Platelet Volume (MPV) (sometimes included)

Pathophysiology

• Mechanism: The CBC reflects the state of hematopoiesis in the bone marrow and the balance of production, destruction, and distribution of blood cells in the peripheral circulation.
  • Erythropoiesis: Regulated by erythropoietin from the kidneys, influenced by oxygen demand, iron stores, vitamins (folate, B12), and marrow function. Abnormalities in these can lead to anemia (low Hb/Hct) or polycythemia (high Hb/Hct). RBC indices (MCV, MCH) help classify anemias (e.g., microcytic, normocytic, macrocytic).
  • Leukopoiesis: Production of various WBCs in response to infection, inflammation, stress, or malignancy. Different cell types increase/decrease depending on the underlying cause (e.g., neutrophilia in bacterial infection, lymphocytosis in viral infection, eosinophilia in allergic reactions).
  • Thrombopoiesis: Platelet production regulated by thrombopoietin. Abnormalities can lead to thrombocytopenia (low platelets) or thrombocytosis (high platelets), affecting hemostasis.
• Risk Factors: Factors increasing the likelihood of conditions that manifest with CBC abnormalities in children:
  • Nutritional deficiencies: Inadequate intake or absorption of iron, folate, vitamin B12 (e.g., strict vegetarian/vegan diet without supplementation, malabsorption, premature birth).
  • Genetic predispositions: Family history of inherited anemias (e.g., thalassemias, sickle cell disease), inherited bone marrow failure syndromes, or immunodeficiencies.
  • Infections: Recurrent or severe infections (e.g., bacterial sepsis, viral infections like Epstein-Barr virus, parvovirus B19).
  • Chronic diseases: Renal disease, inflammatory bowel disease, chronic inflammatory conditions.
  • Exposure to toxins/medications: Certain drugs (e.g., chemotherapeutics, some antibiotics), environmental toxins.
  • Prematurity: Increased risk of anemia due to limited iron stores, rapid growth, and frequent phlebotomy.
• Protective Factors: Measures that reduce the risk of conditions causing CBC abnormalities:
  • Adequate nutrition: Breastfeeding (with iron supplementation for term infants >4-6 months, or sooner if needed), iron-fortified formula, timely introduction of iron-rich solid foods, balanced diet.
  • Immunizations: Protection against vaccine-preventable infections that can cause CBC changes (e.g., measles, pertussis).
  • Good hygiene: Reduces infection transmission.
  • Genetic counselling: For families with known inherited hematologic disorders.
  • Early diagnosis and management: Prompt identification and treatment of underlying conditions.

Clinical Presentation

The CBC is a diagnostic test; therefore, this section describes symptoms and signs that prompt a CBC order in a paediatric patient.

Signs and Symptoms

• Cardinal Features (often prompting a CBC):
  • Pallor: Suggests anemia.
  • Fatigue/Lethargy: Non-specific, but common with anemia or chronic illness.
  • Irritability: Common in infants/toddlers with anemia.
  • Fever: Suggests infection or inflammation; CBC helps assess severity and differentiate causes.
  • Recurrent infections: May suggest neutropenia, lymphopenia, or underlying immunodeficiency.
  • Easy bruising or bleeding: Petechiae, purpura, epistaxis, gingival bleeding, menorrhagia, prolonged bleeding after minor trauma, may indicate thrombocytopenia or platelet dysfunction.
  • Lymphadenopathy/Hepatosplenomegaly: May indicate infection, inflammation, or malignancy.
  • Failure to thrive: Can be associated with chronic anemia or systemic illness.
  • Bone pain: Especially if severe or persistent, can suggest malignancy.
• Early Signs:
  • Mild pallor or decreased activity that parents might notice subtly.
  • Increased frequency of minor infections.
  • Subtle changes in feeding or sleep patterns.
• Advanced Signs:
  • Severe pallor, tachycardia, exertional dyspnea, signs of heart failure (severe anemia).
  • Profound weakness, recurrent severe infections (severe neutropenia or immunodeficiency).
  • Spontaneous severe bleeding (intracranial hemorrhage, severe gastrointestinal bleeding) (severe thrombocytopenia or coagulopathy).
  • Worsening lymphadenopathy, organomegaly, persistent fever, weight loss (malignancy).
• Atypical Presentations:
  • Pica (eating non-food items) in iron deficiency.
  • Restless legs syndrome.
  • Behavioural changes.

Physical Examination

• Inspection:
  • Skin/Mucous Membranes: Pallor (conjunctivae, nail beds, oral mucosa), jaundice (hemolysis), petechiae, purpura, ecchymoses (bleeding disorder), rash (viral infection, vasculitis), skin lesions (e.g., neurofibromatosis stigmata in juvenile myelomonocytic leukaemia).
  • General appearance: Lethargy, irritability, signs of distress, nutritional status.
  • Head/Neck: Lymphadenopathy (cervical, supraclavicular, axillary, inguinal), facial dysmorphism (e.g., in bone marrow failure syndromes).
• Palpation:
  • Abdomen: Hepatosplenomegaly (infection, malignancy, hemolysis, storage diseases).
  • Lymph nodes: Size, consistency, mobility, tenderness.
  • Bones/Joints: Tenderness or swelling (arthritis, malignancy).
• Special Tests: Not directly for CBC, but findings that inform its interpretation or urgency:
  • Developmental assessment: Delays can be associated with chronic illness.
  • Vital signs: Tachycardia (anemia, infection), tachypnea (anemia, infection), fever.

Diagnostic Approach

History Taking

• Key Questions:
  • Chief complaint and duration: What concerns bring the child in? When did it start?
  • Fatigue, pallor, exercise intolerance: Suggestive of anemia.
  • Fever, chills, night sweats: Suggestive of infection, inflammation, or malignancy.
  • Easy bruising, petechiae, prolonged bleeding, epistaxis, menorrhagia: Suggestive of platelet disorder or coagulopathy.
  • Recurrent infections: Suggestive of immunodeficiency or neutropenia.
  • Weight loss, anorexia, failure to thrive: General systemic illness, malignancy.
  • Dietary history: Iron, vitamin B12, folate intake (e.g., exclusive cow's milk consumption in infants, vegan diet).
  • Family history: Anemia (sickle cell, thalassemia, G6PD deficiency), bleeding disorders, immune disorders, cancer.
  • Medications: Recent antibiotics, chemotherapy, other drugs that can affect blood counts.
  • Exposures: Travel history, animal exposure, toxin exposure.
  • Past medical history: Prematurity, chronic illnesses (renal, inflammatory, gastrointestinal), prior transfusions, surgeries.
  • Birth history: Delayed cord clamping (higher Hb), perinatal infections.
• Red Flags:
  • New-onset pallor, severe fatigue, or lethargy without clear explanation.
  • Unexplained fever with neutropenia (febrile neutropenia) or signs of sepsis.
  • New-onset petechiae or purpura, especially with fever or significant bleeding.
  • Persistent lymphadenopathy or hepatosplenomegaly, particularly if progressive or associated with other systemic symptoms (e.g., weight loss, night sweats).
  • Profound cytopenias (Hb <7 g/dL, ANC <500/µL, platelets <20,000/µL) or unexplained pancytopenia.
  • Presence of circulating blasts on peripheral smear.

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC) with Differential: The core diagnostic test.
    • Red Blood Cell Parameters:
      • Hb/Hct: Primary indicators of anemia or polycythemia.
      • RBC Count: Number of red blood cells.
      • MCV (Mean Corpuscular Volume): Average RBC size (femtoliters, fL). Differentiates microcytic (<80 fL), normocytic (80-100 fL), and macrocytic (>100 fL) anemias.
      • MCH (Mean Corpuscular Hemoglobin): Average amount of Hb per RBC (picograms, pg).
      • MCHC (Mean Corpuscular Hemoglobin Concentration): Average Hb concentration in RBCs (g/dL). Helps differentiate hypochromic (low MCHC) from normochromic.
      • RDW (Red Cell Distribution Width): Measure of variation in RBC size (anisocytosis). Elevated in iron deficiency, vitamin B12/folate deficiency, mixed anemias, some hemoglobinopathies.
    • White Blood Cell Parameters:
      • Total WBC Count: Number of white blood cells.
      • Differential Count: Percentage and absolute count of neutrophils, lymphocytes, monocytes, eosinophils, basophils.
        • Absolute Neutrophil Count (ANC): Critical for assessing infection risk (ANC = WBC x % (neutrophils + bands)/100). Severe neutropenia (ANC <500/µL) is a medical emergency.
        • Absolute Lymphocyte Count (ALC): Important for assessing viral infections or immunodeficiency.
    • Platelet Parameters:
      • Platelet Count: Number of platelets.
      • MPV (Mean Platelet Volume): Average platelet size. High MPV can indicate increased platelet production/turnover (e.g., ITP), while low MPV can be seen in hypoproduction.
    • Interpretation in Paediatrics: Crucially, normal ranges for all CBC parameters vary significantly with age. Neonates have very high Hb, MCV, and WBC counts, which rapidly decline and then stabilize through childhood. (See "Special Populations - Pediatric" for detailed age-specific values).
  • Peripheral Blood Smear Review: Often critical for interpreting abnormal CBC results in children. It allows for:
    • Confirmation of automated counts.
    • Identification of abnormal cell morphology (e.g., schistocytes, target cells, sickle cells, spherocytes, teardrop cells, blasts, atypical lymphocytes).
    • Detection of red cell inclusions (e.g., Howell-Jolly bodies).
    • Estimation of platelet number and morphology (e.g., giant platelets).
    • Detection of malarial parasites or other blood-borne organisms.
• Confirmatory (based on CBC findings):
  • Reticulocyte Count: Measures new RBC production; essential for classifying anemia as due to underproduction or destruction/loss. Corrected reticulocyte count (retic % x Hct / normal Hct) or absolute reticulocyte count are preferred.
  • Iron Studies: Serum iron, ferritin, total iron-binding capacity (TIBC), transferrin saturation. Essential for diagnosing iron deficiency anemia. Ferritin is the most sensitive marker for iron stores.
  • Vitamin B12 and Folate Levels: For macrocytic anemia.
  • Hemoglobin Electrophoresis/HPLC: For suspected hemoglobinopathies (sickle cell disease, thalassemias).
  • Direct Antiglobulin Test (DAT/Coombs Test): For suspected autoimmune hemolytic anemia.
  • Genetic Testing: For inherited bone marrow failure syndromes or specific red cell disorders.
  • Infection workup: Blood cultures, viral serology, inflammatory markers (CRP, ESR) if infection is suspected from WBC findings.
  • Bone Marrow Aspiration and Biopsy: Indicated for unexplained cytopenias (especially pancytopenia), suspected leukaemia or lymphoma, or other bone marrow disorders.
• Monitoring:
  • Serial CBCs: To monitor response to treatment for anemia, infection, or malignancy.
  • CBCs during chemotherapy: To monitor myelosuppression and guide treatment.
  • CBCs for chronic conditions: E.g., in children with chronic kidney disease, inflammatory bowel disease, or autoimmune disorders.

Imaging

• Recommended: Imaging is generally not indicated directly for an abnormal CBC but is used to investigate the underlying cause or complications.
  • Chest X-ray: For pulmonary infections, mediastinal mass (e.g., lymphoma).
  • Abdominal Ultrasound: For hepatosplenomegaly, lymphadenopathy.
  • Skeletal Survey/MRI: For bone pain, suspected malignancy, or skeletal abnormalities in certain syndromes.
• Advanced:
  • CT/MRI: For detailed imaging of lymphadenopathy, organomegaly, or suspected malignancy.
  • PET Scan: In staging certain malignancies.

Management

Management is directed at the underlying condition identified or suggested by the CBC results, or the severe implications of abnormal counts.

Acute Management

• Immediate:
  • Severe Anemia (Hb <7 g/dL, or symptomatic anemia): Red blood cell transfusion (typically 10-15 mL/kg packed RBCs over 2-4 hours). Correct underlying cause if possible.
  • Febrile Neutropenia (Fever with ANC <500/µL): Prompt administration of broad-spectrum intravenous antibiotics (e.g., cefepime, piperacillin-tazobactam) after obtaining blood cultures. Hospitalization is usually required.
  • Severe Thrombocytopenia (Platelets <20,000/µL, or <50,000/µL with active bleeding): Platelet transfusion if active bleeding or planned invasive procedure. Identify and treat underlying cause (e.g., IVIG for ITP).
  • Hyperleukocytosis (WBC >100,000/µL, often in leukaemia): Urgent hydration, allopurinol (to prevent tumor lysis syndrome), consideration of leukapheresis (rarely indicated in children) or emergent chemotherapy initiation to prevent complications like leukostasis.
• Stabilization: Address vital signs, ensure adequate oxygenation and perfusion.
• Emergency:
  • Sepsis with profound leukopenia or leukocytosis: Aggressive fluid resuscitation, empiric broad-spectrum antibiotics, vasopressors as needed.
  • Intracranial hemorrhage due to severe thrombocytopenia: Neurosurgical consultation, immediate platelet transfusion.

Chronic Management

• Pharmacological:
  • Iron Deficiency Anemia: Oral iron supplementation (ferrous sulfate 3-6 mg elemental iron/kg/day divided BID or TID, on an empty stomach with vitamin C for absorption). Parenteral iron in severe cases or malabsorption.
  • Vitamin B12/Folate Deficiency: Oral or parenteral supplementation.
  • Autoimmune Hemolytic Anemia/ITP: Corticosteroids (e.g., prednisone 1-2 mg/kg/day), intravenous immunoglobulin (IVIG), rituximab, thrombopoietin receptor agonists (TPO-RAs) for chronic ITP.
  • Chronic Neutropenia: Granulocyte-colony stimulating factor (G-CSF) for specific etiologies (e.g., congenital neutropenia).
  • Malignancy: Chemotherapy, radiation, targeted therapy, immunotherapy, hematopoietic stem cell transplant, as appropriate for the specific diagnosis.
• Non-pharmacological:
  • Dietary counselling: For nutritional deficiencies.
  • Splenectomy: For refractory severe ITP or hereditary spherocytosis in specific cases.
  • Supportive care: Transfusions, infection prevention (e.g., prophylactic antibiotics, careful hygiene), pain management.
• Monitoring:
  • Regular CBCs: To assess treatment response and detect complications.
  • Specific lab tests: Iron studies, vitamin levels, direct antiglobulin test, etc., based on the underlying condition.
  • Growth and development monitoring: Essential in children with chronic hematologic conditions.

Treatment Algorithms

• First-Line:
  • Microcytic Anemia (low MCV): Iron studies. If iron deficient, trial of oral iron. If not, consider hemoglobinopathy workup (electrophoresis).
  • Normocytic Anemia (normal MCV): Reticulocyte count. Low retics suggest underproduction (e.g., chronic disease, renal failure, aplasia, malignancy); high retics suggest hemolysis or acute blood loss.
  • Macrocytic Anemia (high MCV): Vitamin B12 and folate levels, screen for hypothyroidism, liver disease, bone marrow failure.
  • Thrombocytopenia: Rule out pseudothrombocytopenia. Assess for signs of bleeding. Consider ITP, infection, bone marrow failure, autoimmune disease.
  • Leukocytosis: Assess differential. Neutrophilia (bacterial infection, inflammation). Lymphocytosis (viral infection). Eosinophilia (allergy, parasites). Basophilia (CML, chronic inflammation). Monocytosis (chronic infection, inflammation).
  • Leukopenia/Neutropenia: Rule out infection, drug-induced, autoimmune, bone marrow failure.
• Second-Line: Based on initial workup failures or specific diagnoses. E.g., IVIG/corticosteroids for ITP refractory to initial watchful waiting. Bone marrow biopsy for persistent unexplained cytopenias.
• Refractory Cases:
  • For refractory anemias, thrombocytopenias, or neutropenias, consider referral to a paediatric hematologist for advanced diagnostics (e.g., genetic testing, specialized imaging) and treatment options (e.g., bone marrow transplant, novel therapies).

Complications

• Common:
  • Anemia-related: Fatigue, poor concentration, reduced school performance, pica.
  • Neutropenia-related: Increased susceptibility to infections.
  • Thrombocytopenia-related: Easy bruising, epistaxis.
• Serious:
  • Severe Anemia: Heart failure, developmental delay.
  • Severe Neutropenia: Life-threatening bacterial or fungal infections (e.g., sepsis).
  • Severe Thrombocytopenia: Intracranial hemorrhage, severe gastrointestinal bleeding.
  • Leukostasis: In hyperleukocytosis, can lead to respiratory distress, stroke.
  • Tumor Lysis Syndrome: In malignancy with high WBC, can cause acute kidney injury, arrhythmias.
• Long-term:
  • Chronic transfusions: Iron overload (hemosiderosis), alloimmunization.
  • Chronic illness: Growth failure, developmental delay, impaired quality of life.
  • Underlying malignancy: Relapse, secondary malignancies, long-term effects of chemotherapy/radiation.

Prognosis

• Factors: Prognosis is highly dependent on the underlying condition identified by the CBC.
  • Etiology: Benign causes (e.g., iron deficiency anemia, viral infections) generally have excellent prognoses. Malignancies or inherited bone marrow failure syndromes have more guarded prognoses.
  • Severity: Mild abnormalities often resolve spontaneously or with simple interventions. Severe or profound cytopenias/cytoses carry higher morbidity and mortality risks.
  • Timeliness of diagnosis and treatment: Early intervention generally improves outcomes.
  • Presence of complications: Development of serious complications (e.g., sepsis, major hemorrhage) worsens prognosis.
• Survival: Varies widely. Iron deficiency anemia has virtually 100% survival with treatment. Acute lymphoblastic leukaemia (ALL), the most common childhood cancer, has >90% survival in many developed countries. Severe congenital neutropenia or bone marrow failure syndromes can have significantly lower survival rates without definitive treatment like stem cell transplant.
• Quality of Life: Chronic hematologic conditions (e.g., thalassemia major, sickle cell disease, chronic ITP) can significantly impact quality of life due to frequent medical appointments, treatments, and associated symptoms/complications. Early psychosocial support is important.

Prevention

• Primary: Preventing initial occurrence of conditions causing CBC abnormalities.
  • Nutritional counselling: Promotion of breastfeeding, appropriate introduction of iron-rich solid foods (4-6 months), iron-fortified formula, limiting cow's milk intake in infants to <24 oz/day after 12 months, balanced diet throughout childhood.
  • Vaccinations: Routine immunizations against infectious diseases that can cause cytopenias or severe infections (e.g., measles, rubella, varicella, influenza).
  • Screening: Universal newborn screening for sickle cell disease and other hemoglobinopathies in many regions allows for early diagnosis and intervention.
• Secondary: Early detection and intervention.
  • Screening for anemia: Universal screening for iron deficiency anemia at 12 months of age (Hb and/or ferritin) and targeted screening at other ages based on risk factors (e.g., prematurity, low birth weight, lead exposure).
  • CBC as part of routine health checks: Although not always universally recommended for asymptomatic children, a CBC can be useful if there are risk factors or subtle findings.
• Tertiary: Preventing complications in children already diagnosed with a condition.
  • Adherence to treatment: Consistent iron supplementation, regular transfusions for thalassemia, adherence to chemotherapy protocols.
  • Infection prophylaxis: Antibiotics or G-CSF in severe chronic neutropenia.
  • Chelation therapy: For iron overload in transfused patients.

Special Populations

• Pediatric: This is the primary focus of this reference. Age-specific normal ranges are paramount.

  • Neonates (0-28 days):
    • Hb/Hct: Highest at birth (Hb 14-24 g/dL), decreases to a nadir around 2-3 months ("physiologic anemia of infancy"). Term infants typically Hb nadir ~9-11 g/dL, preterm ~7-9 g/dL.
    • MCV: Highest at birth (>95 fL), gradually decreases.
    • WBC: Highest at birth (9,000-30,000/µL), with neutrophilic predominance (ANC 6,000-18,000/µL), then shifts to lymphocytic predominance by 1-2 weeks.
    • Platelets: Adult range (150,000-450,000/µL).
  • Infants (1-12 months):
    • Hb/Hct: Physiologic anemia of infancy resolves. Hb gradually increases towards child ranges.
    • MCV: Continues to decrease, then stabilizes.
    • WBC: Lymphocytic predominance persists.
  • Children (1-12 years):
    • Hb/Hct: Gradual increase.
    • MCV: Stabilizes around 75-87 fL.
    • WBC: Lymphocytic predominance persists until 4-6 years, then gradually shifts back to neutrophilic predominance (similar to adults). Total WBC count gradually decreases.
  • Adolescents (13-18 years): Ranges generally approach adult values, with differences based on sex (e.g., lower Hb in postmenarchal females).

  Approximate Paediatric Normal Ranges (Illustrative - labs may vary):

  Parameter	Birth (Cord)	1-2 Months	6-12 Months	1-6 Years	6-12 Years	12-18 Years
  Hemoglobin	14-24 g/dL	9-14 g/dL	10.5-14.0 g/dL	11.5-14.5 g/dL	11.5-15.0 g/dL	M: 12.0-16.0 g/dL
  						F: 11.5-15.0 g/dL
  MCV	95-120 fL	80-110 fL	70-85 fL	75-87 fL	77-90 fL	M: 78-95 fL
  						F: 78-98 fL
  WBC	9.0-30.0 x 10^9/L	5.0-15.0 x 10^9/L	6.0-17.0 x 10^9/L	5.0-15.0 x 10^9/L	4.5-13.5 x 10^9/L	4.5-13.0 x 10^9/L
  Neutrophils	6.0-18.0 x 10^9/L	1.0-5.0 x 10^9/L	1.5-8.5 x 10^9/L	1.5-8.5 x 10^9/L	2.0-8.0 x 10^9/L	2.0-8.0 x 10^9/L
  Lymphocytes	2.0-11.0 x 10^9/L	2.0-10.0 x 10^9/L	2.0-10.0 x 10^9/L	2.5-9.0 x 10^9/L	1.5-7.0 x 10^9/L	1.0-5.0 x 10^9/L
  Platelets	150-450 x 10^9/L	150-450 x 10^9/L	150-450 x 10^9/L	150-450 x 10^9/L	150-450 x 10^9/L	150-450 x 10^9/L

  • Physiological Anemia of Infancy: Normal, transient decrease in Hb in term infants (nadir ~9-11 g/dL at 2-3 months) due to decreased erythropoiesis post-birth and RBC lifespan shortening. Preterm infants experience a more pronounced and earlier nadir.
  • Lymphocytic Predominance: Children typically have higher absolute lymphocyte counts and a relative lymphocyte predominance in the differential until 4-6 years of age.
  • Benign Ethnic Neutropenia: Common in individuals of African or Middle Eastern descent, with ANC often lower than general population norms but not associated with increased infection risk.
  • Geriatric: Not applicable for this paediatric-focused reference.
  • Pregnancy: Not applicable for this paediatric-focused reference.
  • Comorbidities: The presence of chronic diseases (e.g., renal failure, inflammatory bowel disease, cystic fibrosis, congenital heart disease, endocrinopathies) can significantly impact CBC parameters and must be considered during interpretation.

Clinical Pearls

• Diagnostic:
  • Always interpret paediatric CBC results with age-appropriate normal ranges. What is normal for an adult is often abnormal for a child, and vice versa.
  • Consider pseudothrombocytopenia: Platelet clumping in EDTA tubes can lead to falsely low platelet counts. If suspected, repeat CBC in a citrate or heparin tube or review peripheral smear.
  • Reticulocyte count is key in anemia workup: Helps determine if the bone marrow is responding appropriately.
  • Peripheral smear review is invaluable: Don't rely solely on automated counts, especially with abnormal results or significant clinical suspicion.
  • Elevated RDW with normal MCV: Can be an early sign of iron deficiency.
  • "Shift to the left": Increase in immature neutrophils (bands, metamyelocytes) usually indicates acute bacterial infection.
  • Atypical lymphocytes: Commonly seen in viral infections (e.g., EBV).
• Treatment:
  • Don't over-transfuse: Transfuse only for symptomatic anemia or critically low Hb.
  • Treat the underlying cause: CBC abnormalities are usually a symptom, not the disease itself.
  • Iron absorption: Iron is best absorbed on an empty stomach with vitamin C. Avoid administering with dairy products.
• Pitfalls:
  • Missing physiologic anemia of infancy: Misdiagnosing and over-treating a normal phenomenon.
  • Ignoring a persistently abnormal CBC: Even if mild, persistent abnormalities warrant investigation.
  • Misinterpreting a "normal" CBC in the context of clinical suspicion: A normal CBC does not always rule out significant pathology if clinical suspicion is high (e.g., early infection, some types of leukaemia).
  • Failure to consider nutritional causes of anemia: Especially in toddlers with high cow's milk intake.
  • Over-reliance on automated differential: Always review the smear if atypical cells are suspected or counts are significantly abnormal.

Recent Updates

• Guidelines:
  • Current guidelines continue to emphasize age-specific interpretation and a stepwise approach to investigation of CBC abnormalities.
  • Updated guidelines for management of iron deficiency anemia often focus on prevention, early screening, and appropriate dosing of iron supplementation to minimize side effects.
  • Management of immune thrombocytopenia (ITP) in children increasingly emphasizes observation for mild to moderate cases, with corticosteroids and IVIG reserved for significant bleeding, and newer agents (TPO-RAs) for chronic refractory cases.
• Evidence:
  • Ongoing research refines understanding of genetic causes of various cytopenias and cytoses, leading to improved diagnostic panels and targeted therapies.
  • Advancements in molecular diagnostics for childhood leukemias and lymphomas continue to improve risk stratification and treatment outcomes.
• Controversies:
  • Universal versus targeted screening for anemia: Debate continues on the cost-effectiveness and necessity of universal screening versus targeted screening based on risk factors.
  • Optimal iron supplementation duration and dosage: While general guidelines exist, individualizing treatment based on tolerance and response is important.
  • Management of mild, asymptomatic neutropenia: When to investigate vs. observe, especially in the context of benign ethnic neutropenia.

Key References

• Guidelines:
  • American Academy of Pediatrics (AAP) Clinical Practice Guidelines for Anemia and other hematologic conditions.
  • World Health Organization (WHO) guidelines for the prevention and control of iron deficiency anemia.
  • National Comprehensive Cancer Network (NCCN) Guidelines for paediatric hematologic malignancies.
  • American Society of Hematology (ASH) guidelines for various hematologic disorders.
• Studies: Landmark studies in paediatric hematology (e.g., in ITP management, leukaemia treatment protocols).
• Reviews:
  • Lanzkowsky's Manual of Pediatric Hematology and Oncology (7th ed. or current).
  • Nathan and Oski's Hematology of Infancy and Childhood (8th ed. or current).
  • UpToDate topics on pediatric hematology.
  • Nelson Textbook of Pediatrics (21st ed. or current).